Point mutations in the mitochondrial (mt) tRNA Leu(UUR) gene are responsible for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a subgroup of mitochondrial encephalomyopathic diseases. We previously showed that mt tRNA Leu(UUR) with an A3243G or T3271C mutation derived from patients with MELAS are deficient in a normal taurinecontaining modification (m 5 U; 5-taurinomethyluridine) at the anticodon wobble position. To examine decoding disorder of the mutant tRNA due to the wobble modification deficiency independent of the pathogenic point mutation itself, we used a molecular surgery technique to construct an mt tRNA Leu(UUR) molecule lacking the taurine modification but without the pathogenic mutation. This ''operated'' mt tRNA Leu(UUR) without the taurine modification showed severely reduced UUG translation but no decrease in UUA translation. We thus concluded that the UUG codon-specific translational defect of the mutant mt tRNAs Leu(UUR) is the primary cause of MELAS at the molecular level. This result could explain the complex I deficiency observed clinically in MELAS.
M
itochondrial (mt) DNA mutations are responsible for a wide spectrum of human diseases that are caused by mitochondrial dysfunction. Point mutations in the genes encoding mt tRNAs are found particularly frequently in mitochondrial diseases (MITOMAP: A Human Mitochondrial Genome Database, www.mitomap.org, 2004) (1) . Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), one of the major clinical subgroups of the mitochondrial encephalomyopathies, is caused by a single base replacement in the tRNA Leu gene, which is responsible for the translation of the UUR (R ϭ A or G) leucine codons (tRNA Leu(UUR) ) (2) . The majority (80%) of MELAS patients possess an A to G transition at nucleotide position (np) 3243 (3, 4) , whereas, in Ϸ10% of the patients, a T to C transition is observed at np 3271 (5) . The mutation at np 3243 has also been observed in maternally inherited diabetes with deafness (6) and in progressive external ophthalmoplegia (7, 8) . An A to G transition at np 8344 in the tRNA Lys gene is found in most patients with myoclonus epilepsy associated with ragged red fibers (MERRF) (9) , another major clinical subgroup of the mitochondrial encephalomyopathies. Thus, clinical features depend on the tRNA species and͞or positions of the mutations; however, the molecular mechanisms linking the locations of the mutations and their leading phenotypes are not fully understood.
Cybrid cell lines (10, 11) , in which mutant mtDNA derived from patients was intercellularly transferred into human cells lacking mtDNA ( 0 cells), were used to demonstrate that the above three mutations (A3243G, T3271C, and A8344G) are directly involved in mitochondrial dysfunction. In the case of MELAS, a decline in enzymatic activity and a decrease in protein synthesis were observed in cybrid cells containing a high ratio of mutated mtDNA (12) (13) (14) . Several lines of studies proposed dysfunction of the mutant tRNAs Leu(UUR) as a possible outcome arising directly from the MELAS mutations, which would in turn cause a decrease in respiratory activity (15) . However, there is as yet no conclusive evidence for a molecular mechanism of mitochondrial dysfunction induced by pathogenic point mutations.
We have previously shown that, in cybrid cells possessing homoplasmic pathogenic mutations, the taurine-containing modified uridine (m 5 U; 5-taurinomethyluridine) (16) that normally occurs at the anticodon wobble position of mt tRNA Leu(UUR) remains unmodified in the mt tRNA Leu(UUR) bearing the A3243G or T3271C mutation ( Fig. 1 ) (17) . This finding explains why these different point mutations are associated with the same clinical phenotype. In addition, we have shown by using cybrid cells from a patient with MERRF that the mutant mt tRNA Lys bearing the A8344G mutation also lacks the appropriate taurine-modification (m 5 s 2 U; 5-taurinomethyl-2-thiouridine) (16, 18) . These two types of mitochondrial diseases thus have in common the lack of taurine modification of their respective mutant tRNAs. Thus, the point mutations apparently function to hinder the biosynthesis of the wobble taurine modification of mt tRNAs. Because uridine modifications at the wobble position are responsible for precise and efficient codon recognition (19, 20) , a considerable decoding disorder might be caused by the wobble modification deficiency. In the case of MERRF, we have previously shown that tRNA Lys with a mutation at np 8344 actually does lose translational activity for both of its cognate codons due to the wobble modification defect (21) .
In this study, we estimated the decoding disorder in mitochondrial translation arising from the deficient modification of the wobble taurine of mutant tRNA Leu(UUR) . It is necessary to discriminate the specific effect of the wobble modification deficiency from that of the different point mutations (A3243G or T3271C). We used the molecular surgery technique to construct an mt tRNA Leu(UUR) molecule lacking the taurine modification but without the pathogenic mutation. By clarifying the decoding and translational activities of this ''operated'' tRNA Leu(UUR) , we were able to obtain clear experimenThis paper was submitted directly (Track II) to the PNAS office.
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tal evidence that the mt tRNA Leu(UUR) lacking the wobble taurine modification has a codon-specific deficit in translational ability.
Materials and Methods
Cybrid Cell Lines. The mutant cybrid cell lines, which were constructed by the intercellular transfer of MELAS patient mtDNA to 0 HeLa cells, have been described (17) . The ML2-2-2 and ML5-1-13 cell lines exclusively contain mtDNA with the A3243G and T3271C point mutations, respectively. The cells were cultured in normal medium [Dulbecco's modified Eagle's medium͞F-12 (1:1; GIBCO͞BRL), supplemented with 10% FCS].
Large-Scale Purification of mt tRNA Leu(UUR) from Human Placenta.
Large-scale purification of mt tRNA Leu(UUR) from human placenta was basically carried out according to methods described in the literature (16) . A crude RNA fraction (7.8 g) was extracted from 27 kg of human placenta. The tRNA fraction (3.5 g) was obtained by anion exchange column chromatography by using DEAE-Sepharose fast flow (8 ϫ 73 cm) with linear gradients of NaCl (200-500 mM) and MgCl 2 (8-16 mM) in a buffer containing 20 mM Hepes-KOH (pH 7.5). The fractions enriched with the mitochondrial tRNAs were monitored by dot hybridization (22) and pooled. The mt tRNA Leu(UUR) was purified from the fraction by using an improved solid-phase DNA probe method (23), which we have named ''chaplet'' column chromatography, and a synthetic DNA probe with 3Ј biotin that is complementary to tRNA Leu(UUR) (5Ј-GCGATTACCGG-GCTCTGCCATCTTAA-3Ј). The isolated tRNA Leu(UUR) was incubated at 65°C for 8 min and annealed at room temperature in buffer containing 50 mM Hepes-KOH (pH 7.5) and 10 mM MgCl 2 . Thereafter, 5 mM DTT and 0.3 unit͞l T4 polynucleotide kinase (Toyobo, Tokyo) were added to the mixture, and the dephosphorylation of the 3Ј end of tRNA Leu(UUR) was performed at 37°C for 1 h. Then, the 3Ј end was repaired with mammalian mitochondrial CCA-adding enzyme (24) at 37°C for 1 h by adding 0.04 g͞l CCA-adding enzyme, 1 mM ATP, 1 mM CTP, and 100 mM KCl as final concentrations. The repaired tRNA Leu(UUR) was finally purified by 10% PAGE in a 40-cm gel containing 7 M urea. One hundred sixty micrograms of the purified tRNA Leu(UUR) was obtained.
Mutant mt tRNAs
Leu(UUR) bearing the A3243G or T3271C mutation were purified from the relevant cybrid cells as described (17) .
Molecular Surgery to Construct the Artificial mt tRNA Leu(UUR) with an
Unmodified Uridine at Position 34. Molecular surgery was basically carried out according to methods described in the literature (25) . The hammerhead ribozyme was designed to cleave mt tRNA Leu(UUR) obtained from human placenta at the anticodon wobble position (between positions 34 and 35). The ribozyme sequence 5Ј-GGGACUGUAAAGUUUUCUGAUGAGC-CGAAAGGCGAAAGUUUUAUGCG-3Ј was transcribed in vitro by using T7 RNA polymerase. Eighty micrograms of the purified mt tRNA Leu(UUR) was digested at 37°C for 3 h in a reaction mixture (300 l) containing 50 mM Tris⅐HCl (pH 8.0), 25 mM MgCl 2 , 240 g of the hammerhead ribozyme, and 240 g each of two synthetic DNA probes complementary to the top part of tRNA Leu(UUR) , 5Ј-GCGATTACCGGGCTCTGC-CATCTTAA-3Ј and 5Ј-TGTTAAGAAGAGGAATTGAAC-CTC-3Ј. The synthetic DNA probes are designed to destabilize the tRNA to enhance the accessibility of the ribozyme. The resulting 5Ј and 3Ј half fragments were separated by 10% PAGE in a gel containing 7 M urea. The purified 5Ј half fragment (18 g) was treated with 0.1 M HCl at 0°C for 3 h to cleave the 2Ј,3Ј cyclic phosphate of the 3Ј end and then dephosphor ylated with bacterial alkaline phosphatase (Takara). The m 5 U34 at the 3Ј end of the 5Ј half fragment was removed by periodate oxidation (26). After dephosphorylation, the truncated 5Ј half fragment was ligated with pUp (kindly provided by K. Nishikawa, Gifu University, Gifu, Japan) by using T4 RNA ligase (Takara) at 11°C for 15 h in a reaction mixture containing 50 mM Tris⅐HCl (pH 7.5), 15 mM MgCl 2 , 3.5 mM DTT, 15 g͞ml BSA, 5% PEG 6000, 300 M ATP, 15 M of the 5Ј half fragment, 45 M pUp, and 2.5 units͞l T4 RNA ligase. The ligated 5Ј half fragment and the 3Ј half fragment were incubated at 68°C for 7 min in a reaction mixture consisting of 50 mM Hepes-KOH, 15 mM MgCl 2 , and 10 M of each fragment and then annealed at room temperature. Phosphorylation of the 5Ј end of the 3Ј half fragment and dephosphorylation of the 3Ј end of the 5Ј half fragment were performed simultaneously at 37°C for 30 min by adding 3.5 mM DTT, 15 g͞ml BSA, 300 M ATP, and 0.5 unit͞l T4 polynucleotide kinase (Toyobo). Thereafter, 1.25 units͞l T4 RNA ligase (Takara) was added to the mixture, and the ligation was performed at 37°C for 30 min. The reconstituted tRNA was purified by 12% PAGE in a gel containing 7 M urea. In the end, 5.2 g of the tRNA bearing an unmodified uridine at the wobble position was obtained. The sequence of the resultant tRNA Leu(UUR) was confirmed by Donis-Keller's method (27). In Vitro Mitochondrial Translation. The in vitro translation assay was carried out according to methods described in the literature (28) . Briefly, the aminoacyl-tRNA Leu(UUR) was prepared at 37°C for 10 min in a reaction mixture (50 l Leu(UUR) , and 20 g of human mt leucyl-tRNA synthetase. The leucylation level of WT and the operated tRNAs Leu(UUR) achieved to be 88% and 87%, respectively. Although it is known that leucylation is affected by the MELAS mutation, MELAS tRNA with the 3243 or 3271 mutation was respectively leucylated to be 48% and 80% in the presence of an excess amount of mt leucyl-tRNA synthetase. Poly(UUA) 30 , Poly(UUG) 30 and Poly(UUC) 30 were synthesized in vitro by using T7 RNA polymerase. The reaction mixture (20 l) contained 50 mM Tris⅐HCl (pH 8.6), 15 mM MgCl 2 , 5 mM KCl, 1 mM DTT, 0.5 mM spermine, 2.5 mM phosphoenolpyruvate, 2.5 units͞ml pyruvate kinase, 0.5 mM GTP, 12 pmol mt EF-Tu, 8 pmol mt EF-G, 2 pmol mt ribosome, 4 g of mRNA [Poly-(UUA) 30 , Poly(UUG) 30 and Poly(UUC) 30 ], and 0.1 pmol
Leu(UUR) . The mixture was incubated at 37°C for 15 min, and the radioactivity of the polymerized amino acids was measured by liquid scintillation counting as described (29, 30) .
Ribosomal A-Site Binding. The A-site binding was carried out according to methods described in the literature (31) with slight modifications. The mRNA containing A-site UUA or UUG codon was synthesized in vitro by using T7 RNA polymerase to create the following sequence (A-site codon underlined): 5Ј-GGGUUAACUUUAAGUAAGGAGGUAUACUAUGUUR-UAACUGCAGAAAAAA-3Ј. First, we filled the ribosomal P-site with initiator tRNA in a mixture (10 l) consisting of 5 pmol Escherichia coli 70S ribosome, 2 g of mRNA, 19 pmol E. coli initiator tRNA fMet , 50 mM Tris⅐HCl (pH 7.5), 6.5 mM MgCl 2 , 60 mM KCl, 1 mM DTT, and 0.5 mM spermine, which was incubated at 37°C for 17 min. Thereafter, four different amounts (0.25, 0.5, 0.75, and 1 pmol) of either the WT or operated mt tRNA Leu(UUR) in a mixture (10 l) consisting of 50 mM Tris⅐HCl (pH 7.5), 6.5 mM MgCl 2 , 60 mM KCl, 1 mM DTT, and 0.5 mM spermine were added to the ribosomal mixture, and a nonenzymatic binding reaction was performed at 37°C for 12 min. The amount of tRNA bound was quantified as described in the literature (32) .
Results

Construction of an mt tRNA Leu(UUR) Variant with an Unmodified Wobble
Uridine Using the Molecular Surgery Technique. To investigate the effect of the wobble modification deficiency on the translational activity of tRNA independently of the effect of the pathogenic point mutation itself, we operated on the human native mt tRNA Leu(UUR) using the molecular surgery technique (25) to construct an artificial mt tRNA Leu(UUR) that has a completely normal sequence, with all of the normal modified bases except the m 5 U at the wobble position. For this purpose, a large There is no band for m 5 U34 in the WT tRNA because the modification prevents PhyM digestion, but there is a cleaved band for U34 in the operated tRNA. Arrowheads show the wobble positions in the alkaline ladders. The band corresponding to m 5 U34 is shifted up due to its bulky substituent, whereas U34 shows a normal band in the ladder.
Fig. 3.
Translational activity of the operated tRNA Leu(UUR) without the wobble modification and of the MELAS mutant tRNAs Leu(UUR) . In vitro mitochondrial translation of test mRNAs containing the UUA (Left), UUG (Center), or UUC (Right) (negative control) codons was performed with WT tRNA Leu(UUR) (WT), operated tRNA Leu(UUR) with an unmodified wobble uridine (OP), and two MELAS mutant tRNAs Leu(UUR) that bear the A3243G (3243) or U3271C (3271) mutations and an unmodified wobble uridine. The radioactivity of the [ 3 H]leucyl-tRNA input to the reaction mixture was defined arbitrarily as 100. The averages of three independent experiments with SD values are shown. Fig. 4 . Ability of the operated tRNA Leu(UUR) without the wobble modification to bind to UUR codons. Shown is binding of the WT tRNA Leu(UUR) (filled circles) and the operated tRNA Leu(UUR) that lacks the wobble modification (filled squares) to ribosomal A-sites containing UUA (Left) or UUG (Right). Three independent experiments were performed, and the average values are plotted with SD values.
amount of mt tRNA
Leu(UUR) (160 g) was isolated from 27 kg of human placenta (Fig. 2a) by using a solid-phase DNA probe method as described in Materials and Methods. The purified mt tRNA Leu(UUR) was cut in half at the wobble position by the hammerhead ribozyme (Fig. 2b) . m 5 U in the 5Ј half fragment was removed by periodate oxidation and replaced with an unmodified uridine by enzymatic ligation. Then the 5Ј fragment was re-ligated to the 3Ј half fragment to construct an mt tRNA Leu(UUR) lacking the m 5 U modification ( Fig. 2b ; for details, see Materials and Methods). The sequence of the resultant tRNA was confirmed by Donis-Keller's method (27) (Fig.  2c) . As shown in Fig. 2c , the wobble base of the operated tRNA is cleaved by RNase PhyM (A-or U-specific) to give a discrete band, whereas that of the WT tRNA is resistant to digestion. An unusual upward shift in the alkaline ladders due to the m 5 U modification of the WT tRNA became normal in the ladder of the operated tRNA. Otherwise, we could see no differences in the digestion patterns between these two tRNAs. These results suggest that the resultant operated tRNA had an unmodified wobble uridine but no changes in other modifications.
UUG Codon-Specific Translational Defect of mt tRNAs Leu(UUR) Lacking the Wobble Modification in an in Vitro Mitochondrial Translation
System. We examined whether the mt tRNA Leu(UUR) lacking the wobble modification could function in the translation process. The translational activity was measured by using an in vitro mitochondrial translation system (28) . We used an mRNA transcribed in vitro that has 30 triplet repeats for the leucine codons UUA and UUG, as well as UUC as a negative control. As shown in Fig. 3 , the WT mt tRNA Leu(UUR) was efficient in decoding both the UUA and UUG codons and showed no activity with the UUC noncognate codon. The MELAS mutant tRNAs Leu(UUR) purified from the relevant mutant cybrid cells were also examined. These mutant tRNAs, which not only possess the MELAS A3243G or T3271C mutation but also lack the wobble modification ( Fig. 1) , showed a considerable reduction in UUA decoding as well as a severe reduction in UUG decoding. In the case of the operated tRNA Leu(UUR) , whose wobble modification had been surgically removed, no appreciable reduction was observed in UUA decoding, but a severe reduction was observed in UUG decoding.
Defective Binding of the mt tRNA Leu(UUR) Without the Taurine Modification to the UUG Codon on the Ribosomal A-Site. To confirm that the wobble modification is responsible for UUG decoding, we carried out a ribosomal A-site-binding experiment. Native mt tRNA Leu(UUR) efficiently bound to both the UUA and UUG codons whereas the operated tRNA bearing an unmodified wobble uridine showed strong binding to the UUA codon but weak binding affinity for the UUG codon (Fig. 4) . This finding suggests that the UUG codon-specific translational defect of mt tRNA Leu(UUR) lacking wobble modification is caused by an inability to form codon-anticodon base pairs on the ribosomal A-site. From these results, we conclude that the modified wobble uridine plays a functional role in the decoding of the UUG codon by stabilizing the U:G wobble base pairing on the ribosomal A-site.
Discussion
Many studies have implicated pathogenic point mutations in tRNAs Leu(UUR) in the dysfunctions associated with MELAS mutations (15, 33) . These dysfunctions include impaired termination (34), impaired pre-tRNA processing (35) , decreased stability and aminoacylation (36) , and abnormal conformation (37) , and commonly lead to a decreased steady-state level of the normal aminoacylated tRNA, which in turn leads to reduced protein synthesis. Some of these biochemical tRNA analyses were performed by using an unmodified tRNA transcribed in vitro, because it is difficult to obtain a sufficient number of native mt tRNAs with the MELAS mutation for a series of analyses. However, tRNAs mature through posttranscriptional modifications and do not function without these modifications. Indeed, human mt tRNA Leu(UUR) (78 bases in length) has nine modified bases (11.5% of total bases). In particular, wobble modification plays a crucial role in decoding the genetic code. Our observations suggest that the wobble taurine modification deficiency in MELAS and MERRF should be considered one of the major molecular pathogeneses of these diseases. Although a biochemical study using unmodified tRNAs is a powerful approach for studying mitochondrial diseases in some cases, our observations in the mutant tRNAs from MELAS and MERRF prompted us to carefully estimate the defect of the single posttranscriptional modification using fully modified native tRNAs.
A number of analyses have suggested that the extent of the deficiency in protein synthesis did not seem to parallel the decline in the enzymatic activity of the respiratory complexes in the case of MELAS (12) (13) (14) 35) . Thus, a quantitative decrease in functional mt tRNA Leu(UUR) alone seems insufficient to be the direct cause of the mitochondrial dysfunction, although the mitochondrial dysfunction in MELAS arises from multiple causes. The facts prompted us to consider that some The UUG codon ratio (%) to total leucine codons and to total amino acids (total codons) is shown for each gene. A6 and A8 represent subunits 6 and 8 for ATPase, respectively. qualitative differences could be involved in the molecular pathogenesis of MELAS, including the wobble modification deficiency.
In this study, we successfully clarified the critical effect of the wobble modification deficiency in mt tRNA Leu(UUR) on UUG codon-specific translation by using an in vitro mitochondrial translation system and a ribosome A-site-binding assay. Although the aminoacylation level of four tRNAs Leu(UUR) put into the translation system was not equal (48 -88%; see Materials and Methods), the difference in aminoacylation level and presence of deacylated tRNA could not inf luence the translational activity, because it is likely that almost all leucylated tRNA is trapped by EF-Tu to form the ternary complex (aminoacyl-tRNA͞EF-Tu͞GTP) under the existence of overabundant EF-Tu and that the ribosomal A-site exclusively binds the ternary complex (38) . In the case of the nonenzymatic ribosomal A-site-binding experiment, the aminoacylation level of the two aminoacylated tRNAs was almost equal (88% for WT and 87% for operated), so it hardly became a problem. We used E. coli ribosome instead of the human mitochondrial counterpart in the binding assay, because the precise condition for the assay using E. coli ribosome is completely established and it has been shown that mt tRNA enables translation to proceed on E. coli ribosome and, conversely, that E. coli tRNA dose likewise on mt ribosome (39, 40) .
Our results demonstrate two major points. First, the severe reduction in UUG decoding by the MELAS mutant tRNAs can be mainly attributed to the lack of the wobble modification. Many studies have unraveled the contribution of the position 5-substituted wobble uridines to decoding, including restricting decoding by a modified uridine with a methylene carbon directly bonded to the C5 position of uracil ring (xm 5 U) or expanding decoding by a modified uridine with an oxygen atom directly bonded to the C5 position (xo 5 U) (19, 20, 41, 42) . In this study, we concluded that the taurine modification at the C5 position of wobble uridine (m 5 U) in mt tRNA Leu(UUR) plays a crucial role in the decoding of the UUG codon by stabilizing the U:G wobble base pairing. Second, because there was a considerable reduction in UUA decoding when the point mutations were present but not when they were absent, the MELAS point mutations themselves impose a certain negative effect on translation. Thus, we could estimate the negative effect of the respective pathogenic point mutations (A3243G and U3271C) on decoding the cognate UUA codon, by comparison with the result of the operated tRNA lacking the wobble modification. The negative effect might arise from the fragile relaxed structure caused by the mutations, because the A3243G mutation could disrupt the potential tertiary interaction U8-A14-A21 (43) (44) (45) , and the T3271C mutation destabilizes the anticodon stem (46) . The MELAS tRNA Leu(UUR) with the A3243G mutation showed a more severe reduction in UUA decoding than the tRNA Leu(UUR) with the T3271C mutation. This result is consistent with translational activities of MELAS cybrid cells with these point mutations (12, 14) .
We have noticed a specific bias of leucine codon usage in 13 proteins encoded by human mtDNA genes (Table 1) . For example, despite the minor usage of the UUG codon in most of the proteins, the ND6 gene, which is a component of respiratory chain complex I (NADH-coenzyme Q reductase), contains eight UUG codons that constitute 42.1% of the total leucine codons and 4.6% of the total codons in ND6. It has been reported that the translational activity of ND6 in cybrid cells is specifically and markedly reduced without a decrease in total mitochondrial protein synthesis when the A3243G or T3271C mtDNA levels are increased (13, 14) . Furthermore, a point mutation (A14453G) in the structural gene for ND6 was found to be associated with severe MELAS syndrome (47) .
Considering the UUG codon-specific translational defect described in this study, these facts support the idea that MELAS patients experience a translational depression of ND6. This idea nicely explains why a specific reduction of complex I activity is characteristic of MELAS patients (48, 49) . These results indicate that the UUG codon-specific translational defect caused by defective wobble taurine modification is primarily responsible for the molecular pathogenesis of MELAS. Additionally, our study suggested that the point mutation itself, in particular the A3243G mutation, contributes to the tRNA Leu(UUR) translational defect to a considerable extent. Thus, the level of decoding disorder for each MELAS mutant tRNA should vary with the effect of each pathogenic point mutation.
We previously examined the translational ability of the mutant mt tRNA Lys from MERRF patients that bears the A8344G mutation. This analysis showed that tRNA Lys lacking the m 5 s 2 U-modification are incapable of translating both cognate codons AAA and AAG. This result is due to a complete loss of codon-anticodon pairing on the ribosome (21), because the 2-thio modification of the wobble base is known to be critical for decoding AAR codons (32) . This result explains why MERRF patients show a marked defect in whole mitochondrial translation (21, 50, 51) . Thus, the different symptoms exhibited by MELAS and MERRF patients may be explained by the fact that the mutant tRNAs lacking the wobble modification in these patients show a distinct pattern of codon recognition (Fig. 5) .
In conclusion, our study has unraveled the essential molecular mechanism causing mitochondrial dysfunction in MELAS pathology. A point mutation at nucleotide position 3243 or 3271 in the mtDNA results in a taurine modification deficiency at the anticodon wobble position of the mutant tRNA Leu(UUR) , which subsequently causes a UUG-codon-specific translational defect, possibly leading to a translational depression of ND6. This defective codon-specific translation indicates that the deficiency in taurine modification could be a key to the expression of clinical phenotypes in mitochondrial diseases.
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